AEVAW vs JNJ · rev $9.1M vs P/E 17, rev $49.37B
Aeva Technologies, Inc. Warrants (AEVAW) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Aeva Technologies, Inc. Warrants (AEVAW) is a software - infrastructure company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported AEVAW revenue for 2024-12-31 was $9.1M. Net income was -$152.3M. Revenue was up 110.2% from 2023-12-31 to 2024-12-31. AEVAW currently screens at market cap $0.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
AEVAW currently screens at market cap $0. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the AEVAW and JNJ stock pages for the full models.
Not investment advice.